These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 25867761

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N, Chattopadhyay M, Rodes DB, Nazarenko A, Kodela R, Kashfi K.
    Molecules; 2015 Jul 09; 20(7):12481-99. PubMed ID: 26184135
    [Abstract] [Full Text] [Related]

  • 5. Aspirin and metformin exhibit antitumor activity in murine breast cancer.
    Zhao M, Wang Y, Du C, Liu Y, Zhang N, Luo F.
    Oncol Rep; 2018 Mar 09; 39(3):1414-1422. PubMed ID: 29328467
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.
    Basudhar D, Cheng RC, Bharadwaj G, Ridnour LA, Wink DA, Miranda KM.
    Free Radic Biol Med; 2015 Jun 09; 83():101-14. PubMed ID: 25659932
    [Abstract] [Full Text] [Related]

  • 7. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J, Hahm ER, Marcus AI, Singh SV.
    Mol Carcinog; 2015 Jun 09; 54(6):417-29. PubMed ID: 24293234
    [Abstract] [Full Text] [Related]

  • 8. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L, Liu LJ, Yan YM, Fu R, Li Y, Xu Y, Cheng YX, Wu ZQ.
    J Exp Clin Cancer Res; 2019 Mar 21; 38(1):134. PubMed ID: 30898152
    [Abstract] [Full Text] [Related]

  • 9. Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.
    Chen J, Huang X, Li N, Liu B, Ma Z, Ling J, Yang W, Li T.
    Mol Med Rep; 2020 Dec 21; 22(6):5113-5124. PubMed ID: 33174044
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells.
    Choupani J, Alivand MR, M Derakhshan S, Zaeifizadeh M, S Khaniani M.
    J Cell Physiol; 2019 Jun 21; 234(6):9093-9104. PubMed ID: 30317622
    [Abstract] [Full Text] [Related]

  • 12. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
    Chen TC, Hsu YL, Tsai YC, Chang YW, Kuo PL, Chen YH.
    J Mol Med (Berl); 2014 Jan 21; 92(1):53-64. PubMed ID: 24005829
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties.
    Kastrati I, Litosh VA, Zhao S, Alvarez M, Thatcher GR, Frasor J.
    BMC Cancer; 2015 Nov 04; 15():845. PubMed ID: 26530254
    [Abstract] [Full Text] [Related]

  • 15. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
    Li Y, Zhou X, Liu J, Gao N, Yang R, Wang Q, Ji J, Ma L, He Q.
    Life Sci; 2020 May 01; 248():117454. PubMed ID: 32088211
    [Abstract] [Full Text] [Related]

  • 16. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2+ breast cancer cells by attenuating nuclear factor-κB signaling.
    Xu G, Zhao H, Xu J, Zhang Y, Qi X, Shi A.
    J Ethnopharmacol; 2021 Apr 06; 269():113705. PubMed ID: 33346025
    [Abstract] [Full Text] [Related]

  • 17. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, Uesugi M, Agoulnik S, Taylor N, Funahashi Y, Matsui J.
    Br J Cancer; 2014 Mar 18; 110(6):1497-505. PubMed ID: 24569463
    [Abstract] [Full Text] [Related]

  • 18. Modulation of Apoptosis and Epithelial-Mesenchymal Transition E-cadherin/TGF-β/Snail/TWIST Pathways by a New Ciprofloxacin Chalcone in Breast Cancer Cells.
    Alaaeldin R, Abuo-Rahma GEA, Zhao QL, Fathy M.
    Anticancer Res; 2021 May 18; 41(5):2383-2395. PubMed ID: 33952463
    [Abstract] [Full Text] [Related]

  • 19. Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.
    Madunić J, Horvat L, Majstorović I, Jodłowska I, Antica M, Matulić M.
    Clin Breast Cancer; 2017 Dec 18; 17(8):629-637. PubMed ID: 28456486
    [Abstract] [Full Text] [Related]

  • 20. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M, Kodela R, Nath N, Barsegian A, Boring D, Kashfi K.
    Biochem Pharmacol; 2012 Mar 15; 83(6):723-32. PubMed ID: 22209867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.